Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05535192 · ClinicalTrials.gov registry record · NA
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
A NA study of Breast Cancer and Breast Cancer Female, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 3
- Study locations
NCT05535192 is a NA study of Breast Cancer and Breast Cancer Female that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 270 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05535192, a NA study of Breast Cancer and Breast Cancer Female, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to schedule and at the planned dose.
Conditions Studied
Interventions
- BEHAVIORAL THRIVE
- BEHAVIORAL Health Education Support Program
Study Locations (3)
Massachusetts
- Dana Farber Cancer Institute - Boston
Ohio
- Case Western Reserve University/University Hospitals Cleveland - Cleveland
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05535192
The ClinicalTrials.gov registry entry for NCT05535192 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which THRIVE is the first listed.
NCT05535192 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05535192 about?
NCT05535192 is a clinical study titled "TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients". This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to schedu...
What is the current status of trial NCT05535192?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2023-03-20. Estimated completion is 2027-02-01.
What conditions does trial NCT05535192 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female, Stage II Breast Cancer, Stage III Breast Cancer, Stage I Breast Cancer.
What interventions are being tested in trial NCT05535192?
The interventions under investigation include: THRIVE (BEHAVIORAL), Health Education Support Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05535192?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05535192 being conducted?
This trial has 3 study locations across Massachusetts, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.